The goal of this clinical trial is to find out whether two existing medications-anakinra and tocilizumab-can effectively treat a rare and life-threatening brai…

New Onset Refractory Status EpilepticusNew-Onset Refractory Status EpilepticusFebrile Infection-Related Epilepsy Syndrome (FIRES)

~Estimated

~$10 – $6,250

Yale UniversityNCT07281027

Phase 2

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest (RESTORE)

RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for …

Hypoxia-Ischemia, BrainHeart ArrestStatus Epilepticus+4 more

~Estimated

~$10 – $5,625

University of California, San FranciscoNCT05851391

Phase 4

Early Ketamine Plus Midazolam Versus Ketamine Plus Midazolam for the Treatment of Refractory Status Epilepticus

This pilot feasibility study aims to examine how the timing of ketamine introduction as a third-line anti-seizure medication infusion relates to seizure cessat…

Refractory Status Epilepticus

~Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07177235